Low-level laser therapy in ankle sprains: a randomized clinical trial

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Niedrig dosierte Lasertherapie bei Sprunggelenkdistorsionen: eine randomisierte klinische Studie
Autor:Bie, R.A. de; Vet, H.C.W. de; Lenssen, T.F.; Wildenberg, F.A.J.M. van den; Kootstra, G.; Knipschild, P.G.
Erschienen in:Archives of physical medicine and rehabilitation
Veröffentlicht:79 (1998), 11, S. 1415-1420, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource
Sprache:Englisch
ISSN:0003-9993, 1532-821X
Schlagworte:
Online Zugang:
Erfassungsnummer:PU199901306506
Quelle:BISp

Abstract des Autors

Objective: To test the efficacy of low-level laser therapy on lateral ankle sprains as an addition to a standardized treatment regimen, a trial was conducted in which high-dose laser (5J/cm**2), low-dose laser (0.5J/cm**2), and placebo laser therapy (0J/cm**2) at skin level were compared. Design: Randomized, double-blind, controlled clinical trial with a follow-up of 1 year. Patients, therapists, assessors, and analysts were blinded to the assigned treatment. Setting: An ambulatory care setting. Patients: After informed consent and verification of exclusion criteria, 217 patients with acute lateral ankle sprains were randomized to three groups from September 1, 1993, through December 31, 1995. Interventions: Twelve treatments of 904nm laser therapy in 4 weeks as an adjunct to a standardized treatment regimen of 4 weeks of brace therapy combined with standardized home exercises and advice. The laser therapy device used was a 904nm Ga-As laser, with 25-watt peak power and 5,000 or 500 Hz frequency, a pulse duration of 200nsec, and an irradiated area of 1 cm**2. Primary Outcome Measures: Pain and function as reported by the patient. Results: Intention-to-treat analysis of the short-term results showed no statistically significant difference on the primary outcome measure, pain (p=.41), although the placebo group showed slightly less pain. Function was significantly better in the placebo group at 10 days (p=.01) and 14 days (p=.03) after randomization. The placebo group also performed significantly better on days of sick leave (p=.02) and at some points for hindrance in activities in daily life and pressure pain, as well as subjective recovery (p=.05). Intention-to-treat analysis showed that total days of absenteeism from work and sports were remarkably lower in the placebo group than in the laser groups, ranging from 3.7 to 5.3 and 6 to 8 days, respectively. The total number of relapses at 1 year in the low-dose laser group (n=22) was significantly higher (p=.04) than in the other two groups (high laser, n=13; placebo, n=13). Subgroup analysis to correct for possible confounders did not alter these findings. Conclusions: Neither high- or low-dose laser therapy is effective in the treatment of lateral ankle sprains. Verf.-Referat